NAS:ACIU (Switzerland)  
AC Immune SA logo

AC Immune SA

$ 2.76 +0.19 (+7.39%) 10:08 PM EST
P/E:
At Loss
P/B:
1.18
Market Cap:
$ 230.22M
Enterprise V:
$ 83.97M
Volume:
42.12K
Avg Vol (2M):
79.54K
Also Trade In:
Volume:
42.12K
Market Cap $:
230.22M
PE Ratio:
At Loss
Avg Vol (2-Month):
79.54K
Enterprise Value $:
83.97M
PB Ratio:
1.18
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.
Name Current Vs Industry Vs History
Cash-To-Debt 56.56
Equity-to-Asset 0.93
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.62
Distress
Grey
Safe
Beneish M-Score 52.61
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 52.44
9-Day RSI 49.45
14-Day RSI 48.61
6-1 Month Momentum % -5.56
12-1 Month Momentum % -44.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.85
Quick Ratio 10.85
Cash Ratio 10.33

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.3

Financials (Next Earnings Date:2023-03-22 Est.)

ACIU's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ACIU

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 4.042
EPS (TTM) ($) -0.93
Beta 0.71
Volatility % 33.09
14-Day RSI 48.61
14-Day ATR ($) 0.258754
20-Day SMA ($) 2.79775
12-1 Month Momentum % -44.39
52-Week Range ($) 2.06 - 5.41
Shares Outstanding (Mil) 83.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AC Immune SA Filings

Document Form Filing Date
No Filing Data

AC Immune SA Analysis

Share your research

Headlines

See More
No news.